NEW YORK (GenomeWeb News) - Applied Biosystems said today that it has completed its previously announced acquisition of Agencourt Personal Genomics for approximately $120 million in cash.
Applied Biosystems announced its plans to acquire Agencourt in May. As part of the deal, Beckman Coulter has sold its minority interest in APG to ABI for approximately $50 million in cash. Beckman acquired a 49-percent stake in APG as part of its May 2005 acquisition of Agencourt Biosciences.
ABI said that the APG R&D team will continue to be based in Beverly, Mass., and will join ABI's Molecular and Cell Biology division, based in Foster City, Calif.